NEW YORK (GenomeWeb News) - Transgenomic has named Craig Tuttle president and CEO, effective immediately.
Tuttle replaces Collin D'Silva, who resigned in April. Michael Summers, the company's chief financial officer, served as interim CEO. He will remain CFO, Transgenomic said. D'Silva now chairs Transgenomic's board.
Tuttle formerly served as president and chief operating officer of Duke Scientific, a specialty chemistry manufacturer. Prior to that he was the president of Applied Biotech, a home pregnancy test manufacturer.
Tuttle has also held management positions with Boehringer Mannheim, Bayer Healthcare, and Cetus. He holds a BSc in biochemistry from the University of California, Los Angeles, an MSc in biochemistry from the University of Colorado, and an MBA from St. Mary's College.